TEAS Plus New Application

ELUVOGUE

AbbVie Biotechnology Ltd

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97043169
Filing Date: 09/24/2021

NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular application.


The table below presents the data as entered.

Input Field
Entered
TEAS Plus YES
MARK INFORMATION
*MARK ELUVOGUE
*STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ELUVOGUE
*MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK AbbVie Biotechnology Ltd
INTERNAL ADDRESS 4th Floor, Washington House
*MAILING ADDRESS 16 Church Street
*CITY Hamilton
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY Bermuda
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
HM11
PHONE 847-937-3386
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
*TYPE CORPORATION
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Bermuda
GOODS AND/OR SERVICES AND BASIS INFORMATION
*INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
*FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS INFORMATION
*TRANSLATION
(if applicable)
 
*TRANSLITERATION
(if applicable)
 
*CLAIMED PRIOR REGISTRATION
(if applicable)
 
*CONSENT (NAME/LIKENESS)
(if applicable)
 
*CONCURRENT USE CLAIM
(if applicable)
 
ATTORNEY INFORMATION
NAME Cheryl A. Withycombe
ATTORNEY DOCKET NUMBER ABVT70505
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME AbbVie Inc.
STREET 2525 Dupont Drive
CITY Irvine
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 92612
PHONE 847-937-3386
FAX 847-938-2623
EMAIL ADDRESS cheryl.withycombe@abbvie.com
CORRESPONDENCE INFORMATION
NAME Cheryl A. Withycombe
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE cheryl.withycombe@abbvie.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) trademarks@abbvie.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Plus
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 250
*TOTAL FEES DUE 250
*TOTAL FEES PAID 250
SIGNATURE INFORMATION
* SIGNATURE /Cheryl A. Withycombe/
* SIGNATORY'S NAME Cheryl A. Withycombe
* SIGNATORY'S POSITION Attorney of Record/CA Bar Member
SIGNATORY'S PHONE NUMBER 847-937-3386
* DATE SIGNED 09/23/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 09/30/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

TEAS Plus Application

Serial Number: 97043169
Filing Date: 09/24/2021

To the Commissioner for Trademarks:

MARK: ELUVOGUE (Standard Characters, see mark)
The literal element of the mark consists of ELUVOGUE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, AbbVie Biotechnology Ltd, a corporation of Bermuda, having an address of
      4th Floor, Washington House
      16 Church Street
      Hamilton HM11
      Bermuda
      847-937-3386(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005:  Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services. (15 U.S.C. Section 1051(b)).



The owner's/holder's proposed attorney information: Cheryl A. Withycombe. Cheryl A. Withycombe of AbbVie Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      2525 Dupont Drive
      Irvine, California 92612
      United States
      847-937-3386(phone)
      847-938-2623(fax)
      cheryl.withycombe@abbvie.com
The docket/reference number is ABVT70505.
Cheryl A. Withycombe submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
      Cheryl A. Withycombe
       PRIMARY EMAIL FOR CORRESPONDENCE: cheryl.withycombe@abbvie.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@abbvie.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $250 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Cheryl A. Withycombe/   Date: 09/23/2021
Signatory's Name: Cheryl A. Withycombe
Signatory's Position: Attorney of Record/CA Bar Member
Signatory's Phone Number: 847-937-3386
Signature method: Sent to third party for signature
Payment Sale Number: 97043169
Payment Accounting Date: 09/24/2021

Serial Number: 97043169
Internet Transmission Date: Fri Sep 24 08:08:59 ET 2021
TEAS Stamp: USPTO/FTK-XXX.XXX.XXX.XX-202109240808592
40680-97043169-781adaaa79b65f37f7fd364fd
e8a82fe95885d99d92532ca4d1263fb3f293e7b7
8a-DA-08580124-20210922140910202195

TEAS Plus New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed